American Society of Hematology
Blood VTH Second Opinion Program
Blood Vessels, Thrombosis & Hemostasis is now encouraging submission of manuscripts previously submitted to other reputable journals in the field of vascular biology, thrombosis and hemostasis for a rapid initial editorial evaluation. Submit your revised manuscript, along with the previous reviews and your documented responses, and receive a decision on whether it will be considered for a full peer review within 2 business days! All submissions to the journal should be focused on clinical and mechanistic aspects of normal and abnormal hemostasis and vascular function, including acquired bleeding and thrombotic disorders and disorders involving the venous, arterial, and microvasculature. Let our editorial team of active scientists take a second look at your manuscript.
Learn more and submit your manuscript.
Blood & Blood Advances 2023 Impact Factor
According to the most recently released data on journal impact factor (JIF), Blood’s JIF for 2023 is 21.0 and Blood Advances’ is 7.4. With 168,059 total citations in 2023, Blood continues its long-standing position as the most cited journal in the field of hematology. Blood Advances, part of the Blood Journals portfolio, has increased its total citations by 19% from the previous year, and now ranks among the top 12% of all hematology journals. Both journals are ranked in the top 10 for total citations in 2023, with Blood being the #1 most cited journal, and Blood Advances placing 10th. Of the total citations to the hematology category journals, 25% come from Blood and Blood Advances. With the release of the most recent data, it is evident that Blood Journals portfolio continues to be a trusted source, and a premier place to publish quality research in the field of hematology.
Update from ASH
Announcing ASH's new open-access, peer-reviewed journal, Blood Global Hematology.
Find more information here.
With an impact factor of 21.0, Blood is the most cited peer-reviewed publication in the field of hematology. It provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology.
With an impact factor of 7.4, Blood Advances publishes more peer-reviewed hematology research than any other academic journal worldwide. It is an online-only, open access journal that publishes new content continuously, including original research and important community resources such as the ASH Clinical Guidelines.
Blood Neoplasia is an online-only, open access journal publishing research focused on hematologic malignancies and associated disorders, including leukemia, lymphoma, multiple myeloma, Waldenström macroglobulinemia, hemophagocytic lymphohistiocytosis, myeloproliferative neoplasms, minimal residual disease, and precursor conditions. New content is published continuously.
Blood Vessels, Thrombosis & Hemostasis (Blood VTH) is an online-only, open access journal publishing research focused on thrombosis, hemostasis, and vascular biology, as well as associated disorders, including hemorrhagic disorders and platelet blood disorders. New content is published continuously.